NASDAQ · ORMP
Oramed Pharmaceuticals Inc.
$4.23+$0.07 (+1.68%)
Oramed Pharmaceuticals Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.67% below the high.
Loading market information…
TLV · INCR.TA · ILA
Stock price, earnings
Quote as of Oct 29, 2026, 03:24 PM UTC. Cached market data; not a live quote.
One-year closing-price history · ILA. Historical prices are not a forecast.
InterCure Ltd.’s quoted price sits in the upper half of its reported 52-week range, 43.55% below the high.
52-week range
Go beyond this overview with deeper company research in PortfolioX. Explore more in the app
BEHIND THE RESULTS
Upcoming dates and analyst estimates may change. Fiscal quarters follow InterCure Ltd.’s reporting calendar.
THE COMPANY BEHIND THE TICKER
InterCure Ltd., alongside its affiliated companies, is actively involved in the medical cannabis industry, operating both domestically in Israel and internationally. Their activities encompass the entire spectrum from research and cultivation to production, marketing, and distribution of medical cannabis products. The company's product line features dried cannabis flowers and an oil-based cannabis extract. Additionally, InterCure allocates investments to the biomedical sector. Established in 1994, the firm's main headquarters are situated in Herzliya, Israel.
Latest available per-share figures in ILS. The payout ratio compares dividends with earnings.
About this data · PortfolioX market data, also available in the mobile app. Prices are displayed in the listing currency; dividend amounts use the currency shown in that section. Data availability and update times vary.
Page generated Oct 30, 2026, 05:19 AM UTC. Quotes retain their own timestamp above. Missing values appear as a dash. This page is for information only, not personalized investment advice.
HOW THE BUSINESS IS PERFORMING
Statement amounts use the company’s reporting currency and are not converted to the stock’s listing currency. K = thousand, M = million, B = billion, T = trillion. Cash-flow figures are matched by fiscal year; missing figures appear as a dash.
PUT THE NUMBERS IN CONTEXT
Current metrics alongside available historical medians. A lower multiple or higher margin alone does not establish whether a stock is a good investment.
KEEP COMPARING
$4.23+$0.07 (+1.68%)
Oramed Pharmaceuticals Inc.’s quoted price sits in the upper half of its reported 52-week range, 22.67% below the high.
₪0.75₪0.00 (0.0%)
Geffen Residence & Renewal Ltd’s quoted price sits in the lower half of its reported 52-week range, 16.55% below the high.
₪0.18+₪0.00 (+0.57%)
Bonus BioGroup Ltd.’s quoted price sits in the lower half of its reported 52-week range, 71.1% below the high.
₪0.46-₪0.01 (-1.72%)
BATM Advanced Communications Ltd.’s quoted price sits in the lower half of its reported 52-week range, 44.27% below the high.
₪10.20₪0.00 (0.0%)
Rekah Pharmaceutical Industry Ltd.’s quoted price sits in the lower half of its reported 52-week range, 24.33% below the high.
₪3.49+₪0.25 (+7.75%)
Epitomee Medical Ltd’s quoted price sits in the lower half of its reported 52-week range, 66.73% below the high.
₪2.56-₪0.00 (-0.12%)
Seach Medical Group Ltd’s quoted price sits in the lower half of its reported 52-week range, 24.68% below the high.
$1.62-$0.15 (-8.48%)
Pulsenmore Ltd. Ordinary Shares’s quoted price sits in the lower half of its reported 52-week range, 87.51% below the high.
